President Donald Trump has promised answers soon on a potential shift in national drug policy. In 2024, the Biden administration proposed moving marijuana from the DEA's Schedule 1 to Schedule 3, which wouldn’t make it legal on the federal level but would ease federal restrictions. PBS News' John Yang discussed what that long-anticipated change could mean for marijuana users, businesses and research with Beau Kilmer of RAND's Drug Policy Research Center. | PBS NewsHour